Reviva Pharmaceuticals Stock (NASDAQ: RVPH) stock price, news, charts, stock research, profile.
Open | $1.22 |
Close | $1.22 |
Volume / Avg. | 100.41K / 259.03K |
Day Range | 1.22 - 1.28 |
52 Wk Range | 1.05 - 6.80 |
Market Cap | $34.29M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 15.15% |
Days to Cover | 32.43 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Reviva Pharmaceuticals (NASDAQ:RVPH) through any online brokerage.
Other companies in Reviva Pharmaceuticals’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), CalciMedica (NASDAQ:CALC) and Jaguar Health (NASDAQ:JAGX).
There is no analysis for Reviva Pharmaceuticals.
Reviva Pharmaceuticals has a consensus price target of $15.40.
The stock price for Reviva Pharmaceuticals (NASDAQ: RVPH) is $1.15 last updated July 15, 2024 at 7:28 PM EDT.
There are no upcoming dividends for Reviva Pharmaceuticals.
Reviva Pharmaceuticals’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Reviva Pharmaceuticals.
Reviva Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.